Salute e Benessere

Post-Traumatic Stress Disorder Market Set to Expand Significantly During the…

Key Takeaways from the Post-Traumatic Stress Disorder Market Report Key Takeaways from the Post-Traumatic Stress Disorder Market Report Discover PTSD new treatment @ New Treatments for PTSD Post-Traumatic Stress Disorder Market Dynamics The post-traumatic stress disorder market dynamics are expected to change in the coming years. Therising prevalence of PTSD, along with theemergence of new diagnostic categoriesmodeled on the condition, such as prolonged duress stress...
PR Newswire
26/06/2025

Anti-CCR8 Antibodies Market to Witness Remarkable Growth Trajectory During the…

Key Takeaways from the Anti-CCR8 Antibodies Market Report Key Takeaways from the Anti-CCR8 Antibodies Market Report Discover which indication is expected to grab the major anti-CCR8 antibodies market share @ Anti-CCR8 Antibodies Market Report Anti-CCR8 Antibodies Market Dynamics The anti-CCR8 antibodies market is emerging as a promising area within the broader immuno-oncology landscape, driven by thegrowing interest in targeting immunosuppressive components of the tumor...
PR Newswire
26/06/2025

Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025

thfloor, 75013 Paris, France.At the meeting, during which approximately 57% of voting rights were exercised, resolutions 1 through 23 and resolutions 25 and 26 were adopted, while resolution 24 was rejected, consistent with the recommendations of the board of directors.The Cellectis shareholders' meeting appointed Mr. André Muller as a member of the Company's Board of Directors, with immediate effect. In addition, at the close of the AGM, the term of Mr Axel-Sven Malkomes expired, and...
Nasdaq GlobeNewswire
26/06/2025

Teva Releases Q2 2025 Aide Memoire

Q2 2025 Aide MemoireTeva has prepared this document to assist in the financial modeling of its quarterly results. The document is based on Teva’s prior results, management’s previous commentary about Teva’s business outlook and data from select independent sources. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines...
Nasdaq GlobeNewswire
26/06/2025

Pharmaceutical Cold Storage Market to Reach $34.5 Billion by 2035, Growing at a…

The exceptional growth of the pharmaceutical cold storage market is driven by the increasing demand for temperature-sensitive pharmaceuticals and biologics amid rapid biopharmaceutical innovation. The market's expansion is fueled by stringent regulatory requirements for drug storage and distribution, expanding vaccine distribution networks, and the rising adoption of personalized medicine and cell & gene therapies across global healthcare systems. The exceptional growth of the…
PR Newswire
26/06/2025

Press release: Transparency Notification from Shareholders

Transparency Notification from ShareholdersGhent, Belgium – 26 June 2025 – Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, announces today that it received a transparency notification in relation to the entity listed below, notifying the number of voting rights attached to the shares mentioned next to its name in the table below…
Nasdaq GlobeNewswire
26/06/2025

The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?

The shift reflects more than a funding gap — it signals a structural realignment in how cancer breakthroughs may be brought to market. As public systems face pressure and timelines extend, nimble biotech firms are advancing targeted treatments, combination trials, and regulatory conversations once dominated by legacy institutions. Against this backdrop, market watchers see a pivotal window opening for investors willing to back the next wave of oncology innovation. The shift reflects more than…
PR Newswire
26/06/2025

Dental 3D Printing Market worth $10.06 billion by 2030 with 20.5% CAGR |…

This report segments the dental 3D printing market by product & service, technology, application, end user, and region. This report segments the dental 3D printing market by product & service, technology, application, end user, and region. Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=258228239 Browse in-depth TOC on "Dental 3D Printing Market" 538 - Tables 59 - Figures 418 - Pages By Based on technology,the market for...
PR Newswire
26/06/2025

Kolmar Korea Aims to Capture Global Skincare Market with "Uniquely Korean"…

In response, Kolmar Korea is accelerating its global push by collaborating with brand partners to develop skincare products featuring natural Korean ingredients. A standout example is the Mung Bean pH-Balanced Cleansing Foam, co-developed with skincare brand Beplain. This product reimagines mung beans—used in Korea as a natural cleanser for over 1,000 years—with a low-irritation formula and powerful cleansing effects. With more than 10 million units sold, it has been well-received in markets…
PR Newswire
26/06/2025

STORM Therapeutics Appoints Veteran Cancer Drug Developer Dr. Eric Martin as…

He has advanced several oncology therapeutics into clinical trials, including Plixorafenib (PLX-8394), a RAF (Rapidly Accelerated Fibrosarcoma) inhibitor for BRAF-mutant tumors; Exarafenib (KIN-2787), a next-gen RAF inhibitor; Bezuclastinib (PLX-9486), a KIT (CD117) inhibitor for KIT-driven cancers like GIST; and FGFR (Fibroblast Growth Factor Receptor) inhibitor (KIN-3248) targeting FGFR alterations. Dr. Martin has held senior leadership roles at leading biotech companies, including Kinnate…
PR Newswire
26/06/2025

Ramsay Generale de Sante : Natalie Davis appointment as Chairwoman of the Board

PRESS RELEASEParis, 26th June 2025Ramsay Générale de Santé Board of Directors appoints Natalie Davis as Chairman of the BoardAt its meeting today, the Board of Directors announced the appointment of Natalie Davis as Chairman of the Board of Directors. She succeeds Craig McNally, who is stepping down from this position, which he has held since 2017. "On behalf of the entire Ramsay Santé Group team, I would like to offer Craig McNally our sincerest thanks for his eight years of...
Nasdaq GlobeNewswire
26/06/2025

Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and…

New Study Provides Insight into the Bioavailability of Medical Cannabis Formulations for Therapeutic Treatment The study aimed to assess the pharmacokinetic parameters and relative bioavailability of two D9-tetrahydrocannabinol: cannabidiol (THC:CBD) formulations. (A) An orally administered: Tilray THC:CBD extract and (B) an oromucosally administered nabiximols formulation. This pilot crossover study counterbalanced (1) 1 mL of orally administered Tilray THC:CBD extract (10 mg/mL each of...
Nasdaq GlobeNewswire
26/06/2025

Landmark Study Affirms MolecuLight's Efficacy in Real-Time Bacterial Detection…

"As a co-author of this systematic review and an academic and researcher who utilized MolecuLight's technology in practice, I can attest to the profound impact it has on clinicians' ability to manage complex wounds," said study author Rosemarie Derwin, PhD, MSc, PG Dip, BNS, RGN, RNT, experienced nurse, educator, and researcher at the School of Nursing and Midwifery, Trinity College Dublin. "The real-time visualization of bacteria provides immediate practical information that…
PR Newswire
26/06/2025

BioArctic: Professor Lars Lannfelt to receive the 2025 Hartwig Piepenbrock-DZNE…

Professor Lars Lannfelt founded BioArctic together with Pär Gellerfors in 2003 to develop an antibody treatment based on Lannfelt's groundbreaking discoveries of the role of amyloid-beta protein in Alzheimer's disease. These discoveries are the basis for lecanemab, an antibody treatment developed in collaboration with the Japanese company Eisai. By binding to specific forms of amyloid-beta, which causes Alzheimer's disease, lecanemab helps to clear them from the brain, thereby altering the…
PR Newswire
26/06/2025

Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility

REYKJAVIK, ICELAND (June 26, 2025)— Alvotech (NASDAQ: ALVO, ALVO SDB, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its lenders under the Company’s existing senior secured term loan facility, including GoldenTree Asset Management (collectively, the “Lenders”), have agreed to reduce the rate of interest on its existing senior secured term loan facility (the “Facility”). The...
Nasdaq GlobeNewswire
26/06/2025

Express Yourself in Full Color: Candy Crush Saga® and KIKO Milano Release…

The full line-up includes: The full line-up includes: "There's fun in color, creativity in play, and joy in doing things your own way, and that's exactly what this collection celebrates," saidLuken Aragon, VP of Marketing for Candy Crush Saga at King. "Partnering with KIKO Milano has allowed us to turn the bold spirit of Candy Crush Saga into an invitation for fans to express their individuality, embrace their creativity and add a little more joy to the everyday." "This…
PR Newswire
26/06/2025

New fundraising app Givr wants to restore the UK's reputation as the most…

The "Pay Now, Give Now" revolution The "Pay Now, Give Now" revolution Most of us know "Buy-now, Pay-later" where you split payments into installments. Givr uses the opposite logic to make charity giving easy. You preload shopping credit (say, £50 at Amazon) in the app and spend it whenever convenient. Since the brand receives cash upfront, this smooths operations and avoids fees. In return, up to 10% is donated to your chosen charity. "It's incredible that I…
PR Newswire
26/06/2025

Oncorena's new issue of shares fully subscribed

Börje Haraldsson, CEO and cofounder of Oncorena comments: "The new issue of shares was subscribed by its majority owners, HealthCap, Linc and FSG, together with several smaller shareholders. Thanks to the strong support of investors, key opinion leaders, and patients, it is possible to develop this first-in-class, disruptive therapy for patients in high medical need. Within the next year, we should know if ONC175 lives up to our expectations." Börje Haraldsson, CEO and cofounder of…
PR Newswire
26/06/2025

Discover Energy-Efficient Home Wellness at BETA WELLNESS Rotterdam

Experience OASIS: Award Winning Spas & Swim Spas Experience OASIS: Award Winning Spas & Swim Spas OASIS is BETA WELLNESS's flagship brand for spas, swim spas and pools—ranked among the top five inAustralia, and consistently recognised in the UK with the UK Pool & Spa Awards for Energy Efficiency Gold Standard, as well as multiple "Best Buy" accolades from What Spa? magazine. OASIS Spas UK is also a long-standing What Spa? magazine- approved Brand. InRotterdam, explore...
PR Newswire
26/06/2025

Bavarian Nordic Announces the Initiation of Clinical Trials of Mpox Vaccine in…

First studies to evaluate MVA-BN in infants under 2 years of age and pregnant and breastfeeding women.The multi-partner research project is aimed at expanding access to mpox vaccines for vulnerable populations.COPENHAGEN, Denmark, June 26, 2025– Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of the first of two clinical trials designed to support approval and use of the MVA-BN ®mpox/smallpox vaccine in vulnerable populations: infants under 2 years of age and pregnant...
Nasdaq GlobeNewswire
26/06/2025

Global Orthodontists Gather in China to Explore Smartee's Mandibular…

Attendees highlighted both technological sophistication and patient-centered values during their immersion experience: Attendees highlighted both technological sophistication and patient-centered values during their immersion experience: "The experience inChinaprofoundly shifted my perception of Smartee," stated Dr.Saleem Hasanally(UK), known for his focus on smile aesthetics and personalized care standards. "Initially, I imagined Smartee as a smaller enterprise, but seeing its…
PR Newswire
26/06/2025

Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for…

Saint-Herblain, France, June 26, 2025–Valneva SE, (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced an exclusive agreement with CSL Seqirus, one of the world’s largest influenza vaccine companies, for the marketing and distribution of Valneva’s three proprietary vaccines in Germany. Under the agreed terms, CSL Seqirus will start commercializing Valneva’s single-dose chikungunya vaccine IXCHIQ ®from July 2025, and Valneva’s Japanese Encephalitis vaccine...
Nasdaq GlobeNewswire
26/06/2025

Infosys and the Mental Health Foundation Australia Launch 'Supportive Mind' App…

This initiative is part of Infosys' Corporate Social Responsibility commitment to using technology to foster community well-being. By bridging gaps in mental health awareness, the app seeks to offer actionable solutions for proactive self-care and support. This initiative is part of Infosys' Corporate Social Responsibility commitment to using technology to foster community well-being. By bridging gaps in mental health awareness, the app seeks to offer actionable solutions for proactive...
PR Newswire
26/06/2025

DHODH Inhibitors Market Forecast to Reach New Heights by 2034 Owing to the…

Key Takeaways from the DHODH Inhibitors Market Report Key Takeaways from the DHODH Inhibitors Market Report Discover which indication is expected to grab the major DHODH inhibitors market share @ DHODH Inhibitors Market Report DHODH Inhibitors Market Dynamics The dihydroorotate dehydrogenase (DHODH) inhibitors market is witnessing growing interest due to theenzyme's critical role in the de novo pyrimidine biosynthesis pathway, which is essential for DNA and RNA synthesis...
PR Newswire
25/06/2025
Altri  Comunicati